Stock BVC BATM ADVANCED COMMUNICATIONS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials BATM Advanced Communications Ltd.

Equities

BVC

IL0010849045

Biotechnology & Medical Research

Market Closed - London S.E.
Other stock markets
 11:35:07 2024-04-26 am EDT 		5-day change 1st Jan Change
18.92 GBX -1.43% Intraday chart for BATM Advanced Communications Ltd. -1.43% -6.54%
Apr. 18 BATM wins three-year deal providing Edgility platform to Totalplay AN
Apr. 18 BATM Advanced Communications Lands Three-year Edge Computing Deal in Mexico MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 217.2 560.1 501.1 144.5 112.4 102.8 - -
Enterprise Value (EV) 1 179 523.4 444.7 108.5 112.4 75.72 73.32 67.92
P/E ratio 53.6 x 57.5 x - - -644 x 78.6 x 29.5 x 15.7 x
Yield - - - - - - - -
Capitalization / Revenue 1.76 x 3.05 x 3.58 x 1.24 x 0.92 x 0.72 x 0.65 x 0.6 x
EV / Revenue 1.45 x 2.85 x 3.18 x 0.93 x 0.92 x 0.53 x 0.47 x 0.39 x
EV / EBITDA 18.3 x 26.6 x 15 x 13.5 x 12.1 x 8.06 x 5.51 x 3.77 x
EV / FCF 61.4 x 34.7 x 3,447 x -11.5 x - 189 x 27.2 x 14.8 x
FCF Yield 1.63% 2.88% 0.03% -8.7% - 0.53% 3.68% 6.77%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 440,279 440,434 440,434 436,039 436,039 436,189 - -
Reference price 2 0.4933 1.272 1.138 0.3314 0.2578 0.2357 0.2357 0.2357
Announcement Date 3/4/20 2/22/21 2/28/22 3/6/23 3/12/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 123.4 183.6 140 116.1 122.8 143 157 172.5
EBITDA 1 9.8 19.71 29.64 8.025 9.3 9.4 13.3 18
EBIT 1 5.276 14.95 24.38 3.134 1.648 2.9 6.6 11.1
Operating Margin 4.28% 8.14% 17.41% 2.7% 1.34% 2.03% 4.2% 6.43%
Earnings before Tax (EBT) 1 4.778 13.3 24.93 1.895 1.461 2.8 6.5 10.9
Net income 1 3.917 9.793 14.34 0.244 -0.193 1.3 3.7 6.5
Net margin 3.17% 5.33% 10.24% 0.21% -0.16% 0.91% 2.36% 3.77%
EPS 2 0.009200 0.0221 - - -0.000400 0.003000 0.008000 0.0150
Free Cash Flow 1 2.914 15.07 0.129 -9.444 - 0.4 2.7 4.6
FCF margin 2.36% 8.21% 0.09% -8.13% - 0.28% 1.72% 2.67%
FCF Conversion (EBITDA) 29.73% 76.48% 0.44% - - 4.26% 20.3% 25.56%
FCF Conversion (Net income) 74.39% 153.92% 0.9% - - 30.77% 72.97% 70.77%
Dividend per Share - - - - - - - -
Announcement Date 3/4/20 2/22/21 2/28/22 3/6/23 3/12/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 38.2 36.7 56.5 36 - 27.1 29.5 34.9
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 2.91 15.1 0.13 -9.44 - 0.4 2.7 4.6
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 0.69 3.39 3.29 4.47 - 3.9 4.3 4.7
Capex / Sales 0.56% 1.84% 2.35% 3.85% - 2.73% 2.74% 2.72%
Announcement Date 3/4/20 2/22/21 2/28/22 3/6/23 3/12/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for BATM Advanced Communications Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

1st Jan change Capi.
BATM ADVANCED COMMUNICATIONS LTD. Stock BATM Advanced Communications Ltd.
-6.54% 103M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-20.45% 10.82B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+43.17% 3.25B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-35.86% 2.11B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-17.21% 2.08B
VERACYTE, INC. Stock Veracyte, Inc.
-29.81% 1.48B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+17.56% 1.02B
SEEGENE, INC. Stock Seegene, Inc.
-4.37% 733M
CAREDX, INC Stock CareDx, Inc
-37.00% 391M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-46.94% 383M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. BVC Stock
  4. Financials BATM Advanced Communications Ltd.